FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
Nakajima, Erica C, Vellanki, Paz J, Larkins, Erin, Chatterjee, Somak, Mishra-Kalyani, Pallavi S, Bi, Youwei, Qosa, Hisham, Liu, Jiang, Zhao, Hong, Biable, Missiratch, Hotaki, Lauren Tesh, Shen, Yuan-Li, Pazdur, Richard, Beaver, Julia A, Singh, Harpreet, Donoghue, Martha
Published in Clinical cancer research (01.02.2022)
Published in Clinical cancer research (01.02.2022)
Get full text
Journal Article
U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non‐Small Cell Lung Cancer Following Disease Progression On or After Platinum‐Based Chemotherapy
Larkins, Erin, Scepura, Barbara, Blumenthal, Gideon M., Bloomquist, Erik, Tang, Shenghui, Biable, Missiratch, Kluetz, Paul, Keegan, Patricia, Pazdur, Richard
Published in The oncologist (Dayton, Ohio) (01.11.2015)
Published in The oncologist (Dayton, Ohio) (01.11.2015)
Get full text
Journal Article